Translation Support for Clinical Affairs Managers

Clinical Affairs Managers handle clinical documentation that carries regulatory, evidence-based and patient-facing implications, including clinical evaluation, CERs, PMCF, PMS, clinical trial documents and investigator materials. Specialist translation workflows help maintain consistent clinical terminology, version control and traceability across multilingual versions of these documents. Qualified medical and clinical linguists, validated glossaries, translation memories and ISO-aligned processes reduce the risk of inconsistency or rework during clinical, ethics, sponsor or notified body reviews. Specialist workflows support clinical documentation quality, but do not replace clinical, regulatory or ethics decisions made by your internal teams.

Clinical trial translation services cover the multilingual adaptation of content used in clinical trials, including protocols, investigator brochures, informed consent forms, patient information sheets, site instructions, training materials, ethics committee documents, regulatory submissions, clinical study reports, safety communications, adverse event narratives and patient recruitment materials. The goal is accurate, complete and source-faithful translation aligned to the approved source, supported by qualified clinical linguists, controlled terminology and traceable workflows. Clinical trial translation services support multilingual clinical operations but do not replace ethics approval, regulatory approval, sponsor decisions or site readiness, which remain with the responsible internal and external stakeholders.

Clinical evaluation translation is the multilingual adaptation of clinical evaluation content used to demonstrate clinical evidence for medical devices and other regulated products. It typically covers clinical evaluation reports, evidence summaries, literature reviews, clinical data appraisals and supporting references. Clinical evaluation translation needs careful handling of clinical terminology, study references, citations and version history. AbroadLink supports clinical evaluation translation through qualified medical and clinical linguists, terminology control and traceable workflows. Final clinical evaluation, evidence sufficiency and regulatory acceptance remain with the manufacturer, the Clinical Affairs Manager and qualified clinical and regulatory reviewers for each market.

CER translation is the translation of Clinical Evaluation Reports used in regulated environments, particularly under MDR and IVDR for medical devices. CERs include clinical background, intended use, state of the art, clinical data analysis, conclusions and supporting appendices. CER translation requires consistent terminology, careful handling of references, version control across updates and qualified clinical linguists familiar with regulated clinical documentation. AbroadLink supports CER translation through structured workflows, terminology resources and traceable evidence through CertLink. CER acceptance, notified body decisions and clinical sufficiency remain with the manufacturer and its clinical and regulatory teams.

PMCF translation is the translation of Post-Market Clinical Follow-up content, including PMCF plans, PMCF reports, supporting evaluations and related post-market documentation under MDR and similar frameworks. PMCF translation often interacts closely with PMS content and clinical evaluation updates, requiring consistent terminology, version control and traceability across product families and target markets. AbroadLink supports PMCF translation through specialised medical linguists, validated terminology and structured workflows. Final clinical conclusions, post-market follow-up decisions and regulatory acceptance remain with the manufacturer, the Clinical Affairs Manager and the qualified internal and external reviewers responsible for the product.

AI can be used in a controlled way for suitable clinical content, but it should not be used as an uncontrolled, generic translation source for regulated clinical documentation. Through aiHubLink, AbroadLink uses customised generative AI as a pre-translation step based on your terminology and legacy translations, always followed by qualified human review and validation by experienced medical and clinical linguists. For CERs, PMCF, PMS, clinical trial documents, informed consent forms, patient-facing content and authority-facing clinical material, AI is positioned only as a controlled support option, with documented human review, traceability and certificate-backed evidence.

No. Clinical translation helps you produce accurate, traceable multilingual content aligned to your approved source, but it does not guarantee clinical validity, clinical evidence sufficiency, regulatory acceptance, notified body acceptance, competent authority acceptance, ethics approval, trial success, safe use, patient understanding, product approval or market access. Clinical strategy, clinical evaluation conclusions, PMCF and PMS decisions, ethics submissions, regulatory submissions and final content approval remain with the manufacturer, the Clinical Affairs Manager, sponsors, CROs and qualified internal and external reviewers. AbroadLink acts as a specialised language partner supporting your clinical and quality processes.

CertLink is AbroadLink's portal for accessing translation certificates linked to your projects. Each certificate is signed and includes the project code, languages, documents, linguists involved and, where relevant, information about controlled AI use during pre-translation. For Clinical Affairs Managers, CertLink provides a centralised, searchable place to retrieve evidence of translation work across CERs, PMCF, PMS, clinical evaluation files and trial-related content, which can support audits, sponsor questions, notified body reviews and internal QMS records. It complements, but does not replace, your internal clinical documentation, regulatory files and quality records.